Is Nexavar cost covered by Medicare?
Medicare may pay for Nexavar depending on your Part D plan, but you may still be responsible for some of the costs or a copay. You can contact your Medicare Prescription Part D plan or Medicare Advantage Plan and ask them if Nexavar or the generic is on their formulary and your price.
Generic options for medications are often covered under Medicare plans, but you may still have to qualify through a prior authorization, which is paperwork that your doctor will submit.
Your costs can vary depending on if you have insurance copays, coinsurance, need to meet a deductible, have administration fees, and what state you live in. Be sure to speak with your healthcare provider about medication costs before treatment, including costs to administer the medication and any generic options.
Most people without Medicare do not pay the full price for Nexavar or the generic, but get help covering the cost through private insurance or patient assistance programs.
If you do not have insurance, patient assistance programs from the manufacturer or through non-profit organizations may be able to provide financial assistance.
Drugs.com Price Guide: You can view the most up-to-date prices and find a discount coupon here:
Prices can vary based on your pharmacy and location. Quoted prices are for cash-paying customers and are not valid with insurance plans. This price guide is based on using the Drugs.com discount card which is accepted at most U.S. pharmacies.
How do I get Nexavar?
This medicine will be mailed to you from a specialty pharmacy after your doctor prescribes it. You will not usually pick it up from your regular pharmacy.
Specialty medicines are often very expensive medicines that may require special prior authorization from your insurance company or monitoring for the drug’s safety and effectiveness.
Learn more: How does Nexavar work? Is it a chemo drug?
Related questions
- How does Nexavar work? Is it a chemo drug?
- How effective is Nexavar? Does it shrink tumors?
- Lenvatinib vs sorafenib: for first line treatment in HCC?
Why is Nexavar prescribed?
Nexavar (sorafenib) is classified as a vascular endothelial growth factor (VEGF) inhibitor and tyrosine kinase inhibitor (multikinase inhibitor). It is used to treat:
- liver cancer (hepatocellular carcinoma or HCC) that cannot be removed with surgery.
- thyroid cancer called differentiated thyroid carcinoma (DTC) that has spread or recurred and is not responsive to radioactive iodine treatment.
- advanced kidney cancer (renal cell carcinoma or RCC).
The recommended dose of Nexavar (sorafenib) is 400 mg orally twice daily without food (at least 1 hour before or 2 hours after a meal). Based on side effects, your doctor may need to adjust your dose. Always follow your doctor’s dosing directions exactly.
Nexavar was first approved by the FDA in 2005 and is manufactured by Bayer Healthcare.
This is not all the information you need to know about Nexavar (sorafenib) for safe and effective use. Review the full drug product information and discuss this information and any questions you have with your doctor or other health care provider.
References
- Nexavar (sorafenib) prescribing information. 8/2023. Bayer Healthcare. Accessed Mar 18, 2024 at https://labeling.bayerhealthcare.com/html/products/pi/Nexavar_PI.pdf
- Drugs.com Price Guide. Accessed Mar 18, 2024 at https://www.drugs.com/price-guide/
Read next
What is the success rate of Keytruda?
In general, PD-1 immune checkpoint inhibitors like Keytruda have been shown to significantly prolong overall survival (OS) in some patients with various cancer types, but Keytruda does not always work for everyone. Continue reading
How long does it take for Keytruda to work?
The time it takes for Keytruda to work can vary based on the type and stage of cancer. Typically, a response to treatment becomes apparent within 2-4 months of starting Keytruda. This timeframe is referred to as "time to response," which measures when a patient's cancer begins to show signs of responding to the treatment. You can find the specific "time to response" data from clinical trials in the table below. Continue reading
What is the difference between Opdivo and Keytruda?
Opdivo (nivolumab) and Keytruda (pembrolizumab) are two immunotherapy drugs for various cancers. Both are monoclonal antibodies, known as PD1 inhibitors, first approved in 2014. Opdivo is from Bristol Myers Squibb, and Keytruda is from Merck & Co. The main differences lie in dosing, combination therapies, and approved cancer types. Continue reading
Related medical questions
- Pembrolizumab vs. nivolumab: How do they compare?
- How long does it take for Lenvima to work?
- How long do you take Lenvima?
- How much does Afinitor cost per month?
- How are Inlyta and Keytruda used in kidney cancer?
- What is the success rate of Cabometyx (cabozantinib)?
- What is the difference between Mvasi and Avastin?
- How long can you take Afinitor for?
- Does Votrient cure cancer or shrink tumors?
- What type of drug is Lenvima? Is it a chemo drug?
- How long do you take Sutent before it starts to work?
- How effective are Opdivo and Yervoy when taken together?
- Does Sutent shrink tumors?
- Does Cabometyx (cabozantinib) cure cancer?
- How effective is Lenvima?
- How long does Votrient stay in your system?
- Is Sutent considered a chemotherapy drug?
- Opdivo vs Opdivo Qvantig: What is the Difference?
- Is Votrient a chemotherapy treatment?
- Is Votrient immunotherapy?
- What is the difference between Cabometyx and Cometriq?
- Who makes Bavencio and where is it made?
- What type of drug is Bavencio?
Drug information
Related support groups
- Sorafenib (4 questions, 4 members)
- Nexavar (4 questions, 27 members)
- Renal Cell Carcinoma (32 questions, 103 members)
- Hepatocellular Carcinoma (22 questions, 23 members)
- Thyroid Cancer (13 questions, 44 members)
- Hepatic Tumor (3 questions, 4 members)